Humacyte, Inc.·4

May 18, 6:16 PM ET

Sander Dale A. 4

4 · Humacyte, Inc. · Filed May 18, 2022

Insider Transaction Report

Form 4
Period: 2022-05-17
Sander Dale A.
CFO and Chief Corp. Deve. Off.
Transactions
  • Purchase

    Common Stock

    2022-05-17$4.53/sh+2,000$9,0602,000 total

Documents

1 file
  • 4
    tm2216009-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT